Podrobno

Calprest ELISA vs. Liaison® chemiluminescence : evaluating accuracy, efficiency, and clinical utility in fecal calprotectin testing
ID Osredkar, Joško (Avtor), ID Ekart, Nina (Avtor), ID Drobne, David (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (949,23 KB)
MD5: C7D8A625DC49362780CCB9D3C180F2D9
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2227-9059/14/1/143 Povezava se odpre v novem oknu

Izvleček
Background: Ulcerative colitis (UC) management relies on accurately assessing disease activity. Fecal calprotectin (FC) is a promising non-invasive biomarker, but method-specific differences in measurement can affect interpretation. Objective: To compare the performance of Calprest ELISA and DiaSorin Liaison CLIA in measuring FC concentrations and their correlation with endoscopic findings in UC. Methods: Stool samples from 40 UC patients were analyzed using both methods, with 138 samples collected across three clinical timepoints. Spearman’s correlation, Wilcoxon test, Bland–Altman analysis, and ROC curves were used to evaluate method agreement and diagnostic performance relative to Mayo endoscopic scores. Results: A total of 135 paired results showed strong correlation (ρ = 0.795, p < 0.001) but significant inter-method differences (p = 0.039). Liaison tended to yield higher FC values. ROC analysis established optimal cut-offs for detecting endoscopic remission and active disease: 47.95/69.55 µg/g (Liaison) and 65/125 µg/g (Calprest). Calprest demonstrated slightly better diagnostic accuracy. Conclusions: Both methods are reliable for monitoring UC activity. Calprest offers greater dynamic range, while Liaison excels in automation and speed. Method-specific thresholds should guide clinical interpretation to ensure accurate disease monitoring.

Jezik:Angleški jezik
Ključne besede:ulcerative colitis, fecal calprotectin, statistical analysis, endoscopy, ELISA, CLIA, endoscopic Mayo index
Vrsta gradiva:Članek v reviji
Tipologija:1.03 - Drugi znanstveni članki
Organizacija:FFA - Fakulteta za farmacijo
MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2026
Št. strani:11 str.
Številčenje:Vol. 11, issue 1, art. 143
PID:20.500.12556/RUL-179607 Povezava se odpre v novem oknu
UDK:616.348-002
ISSN pri članku:2227-9059
DOI:10.3390/biomedicines14010143 Povezava se odpre v novem oknu
COBISS.SI-ID:264601091 Povezava se odpre v novem oknu
Datum objave v RUL:18.02.2026
Število ogledov:295
Število prenosov:128
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Biomedicines
Skrajšan naslov:Biomedicines
Založnik:MDPI
ISSN:2227-9059
COBISS.SI-ID:523006745 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:ulcerozni kolitis, fekalni kalprotektin, statistična analiza, endoskopija, ELISA, CLIA, endoskopski Mayo indeks, ulcerozni kolitis, endoskopija

Projekti

Financer:University Medical Centre Ljubljana
Številka projekta:20210034

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj